2,099 reports of this reaction
5.7% of all AXITINIB reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for AXITINIB, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 2,099 FDA adverse event reports linking AXITINIB to FATIGUE. This represents approximately 5.7% of all 37,114 adverse event reports for this drug.
Patients taking AXITINIB who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among AXITINIB users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for AXITINIB:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 2,099 FDA reports for AXITINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 5.7% of all adverse event reports for AXITINIB, making it one of the most commonly reported side effect.
If you experience fatigue while taking AXITINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.